Coincidence of nonpuerperal mastitis and noninflammatory breast cancer

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 105, Issue 1, 2002, Pages 59-63

  Peters, Friedolf ^a   Kießlich, Anja ^a   Pahnke, Volker ^b  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^b Department of Obstetrics and Gynecology   (Germany)

Author keywords

Breast abscess; Breast cancer incidence; Nonlactational mastitis; Nonpuerperal mastitis

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BREAST CANCER; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER RISK; CANCER SCREENING; CONTROLLED STUDY; ECHOGRAPHY; FEMALE; GROUPS BY AGE; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MASTITIS; PRIORITY JOURNAL; PUERPERIUM;

EID: 0037057985     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-2115(02)00109-4     Document Type: Article

References (19)

1. Peters F., Geisthövel F., Schulze-Tollert J., Pfleiderer A., Breckwoldt M. Die nonpuerperale Mastitis. Ätiologie, Klinik Therapie. Dtsch. Med. Wschr. 110:1985;97-104.
2. Pahnke V.G., Kitschke H.J., Bernauer M., Koll R. Mastitis nonpuerperalis - Eine Erkrankung mit zunehmender Relevanz? Geburts Frauenheilk. 45:1985;29-35.
3. Peters F. Die nonpuerperale Mastitis. Gynäkologe. 34:2001;930-939.
4. Geshon-Cohen J., Ingleby H. Secretory disease and plasma cell mastitis in the female breast. Surg. Gynecol. Obstet. 95:1952;497-504.
5. Dixon J.M. Periductal mastitis and duct ectasia: an update. Breast. 7:1998;128-130.
6. Bundred N.J., Dover M.S., Aluwihare N., Faragher E.B., Morrison J.M. Smoking and periductal mastitis. Brit. Med. J. 307:1993;772-773.
7. Dahlbeck S.W., Donelly J.F., Theriault R.L. Differentiating inflammatory breast cancer from acute mastitis. Am. Fam. Phys. 52:1995;929-934.
8. Kilgore A.R., Fleming R. Abscesses of the breast. Recurring lesions in the areolar area. Calif. Med. 77:1952;190-191.
9. Sloop F.B. Jr., Wilhelm M.C. Noninflammatory carcinoma of the breast as benign mastitis. Breast. 6:1981;29-31.
10. Consensus Meeting of the Cancer Committee of the College of American Pathologists. Is fibrocystic disease of the breast precancerous? Arch Pathol Lab Med 1986;110:171-3.
11. Chang S., Parker S.L., Pham T., Buzdar A.U., Hursting S.D. Inflammatory breast carcinoma incidence and survival. Cancer. 82:1998;2366-2372.
12. Breslow N.E., Day N.E. International agency for research on cancer: statistical methods in cancer research. Volume II-the design and analysis of cohort studies. IARC Sci. Publ. 82:1987;65-71.
13. Kreienbrock L, Schach S. Epidemiologische Methoden. Gustav Fischer. New York: Stuttgart-Jena, 1995. p. 35-40.
14. Brinton LA, Devesa SS. Etiology and pathogenesis of breast cancer. In: Morrow M, Hellmann S, editors. Incidence, Demographics, and Environmental Factors. In: Harris JR, Lippmann ME, editors. Diseases of the Breast. Lippincott: Raven, 1996. p. 159-68.
15. Kopans DB. Imaging analysis of breast lesions. In: Harris JR, Lippmann ME, Morrow M, Osborne CK, editors. Diseases of the Breast. 2nd ed. Lippincott: Raven, 2000. p. 123-47.
16. Morgan M.P., Cooke M.M., Christopherson P.A., Westfall P.R., McCarthy G.M. Calcium hydroxyapatite promotes mitogenesis and matrix metalloproteinase expression in human breast cancer cell lines. Mol. Carcinog. 32:2001;111-117.
17. Harris R.E., Namboodiri K.K., Farrar W.B. Nonsteroidal anti-inflammatory drugs and breast cancer. Epidemiology. 7:1996;203-205.
18. Khuder S.A., Mutgi A.B. Breast cancer and NSAID use: a meta-analysis. Cancer. 84:2001;1188-1192.
19. Sotiriou C., Lacroix M., Lagneaux L., Berchem G., Body J.J. The aspirin metabolite salicylate inhibits breast cancer cells growth and their synthesis of the osteolytic cytokines interleukins-6 and -11. Anticancer Res. 19:1999;2997-3006.